A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Certain GLP-1 weight loss medications will be available for as little as $149 per month, a sharp drop from the current ...

Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to expand access to its obesity medicines and re ...

President Donald Trump’s deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some ...

By subsidizing Wegovy and Zepbound, Trump may deliver one of the most consequential public-health interventions in decades.

A new deal between the White House and pharmaceutical companies like Novo Nordisk and Eli Lilly is shaking things up.

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

The Metsera deal is about winning the obesity drugs' market that’s expected to reach US$100 billion by 2030. Read more at ...

For standard GLP-1 usage, Roslin said that patients are started with a low dose and titrated up to clinical effect. That ...

Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the ...